###begin article-title 0
###xml 43 69 43 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 43 69 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Kinetics and Ligand-Binding Preferences of Mycobacterium tuberculosis Thymidylate Synthases, ThyA and ThyX
###end article-title 0
###begin p 1
Conceived and designed the experiments: PR JH. Performed the experiments: JH CP. Analyzed the data: PR JH. Contributed reagents/materials/analysis tools: JH RG CP. Wrote the paper: PR JH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 257 272 257 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 362 377 362 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 57 63 <span type="species:ncbi:9606">people</span>
###xml 257 272 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 362 377 <span type="species:ncbi:1773">M. tuberculosis</span>
Mycobacterium tuberculosis kills approximately 2 million people each year and presents an urgent need to identify new targets and new antitubercular drugs. Thymidylate synthase (TS) enzymes from other species offer good targets for drug development and the M. tuberculosis genome contains two putative TS enzymes, a conventional ThyA and a flavin-based ThyX. In M. tuberculosis, both TS enzymes have been implicated as essential for growth, either based on drug-resistance studies or genome-wide mutagenesis screens. To facilitate future small molecule inhibitors against these proteins, a detailed enzymatic characterization was necessary.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 668 683 668 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 706 709 706 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 777 792 777 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 668 683 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 777 792 <span type="species:ncbi:1773">M. tuberculosis</span>
After cloning, overexpression, and purification, the thymidylate-synthesizing ability of ThyA and ThyX gene products were directly confirmed by HPLC analysis of reaction products and substrate saturation kinetics were established. 5-Fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) was a potent inhibitor of both ThyA and ThyX, offering important clues to double-targeting strategies. In contrast, the folate-based 1843U89 was a potent inhibitor of ThyA but not ThyX suggesting that it should be possible to find ThyX-specific antifolates. A turnover-dependent kinetic assay, combined with the active-site titration approach of Ackermann and Potter, revealed that both M. tuberculosis enzymes had very low kcat values. One possible explanation for the low catalytic activity of M. tuberculosis ThyX is that its true biological substrates remain to be identified. Alternatively, this slow-growing pathogen, with low demands for TMP, may have evolved to down-regulate TS activities by altering the turnover rate of individual enzyme molecules, perhaps to preserve total protein quantities for other purposes. In many organisms, TS is often used as a part of larger complexes of macromolecules that control replication and DNA repair.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 67 82 67 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 201 216 201 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 67 82 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 201 216 <span type="species:ncbi:1773">M. tuberculosis</span>
Thus, the present enzymatic characterization of ThyA and ThyX from M. tuberculosis provides a framework for future development of cell-active inhibitors and the biological roles of these TS enzymes in M. tuberculosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 66 92 66 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Keeler1">[1]</xref>
###xml 350 353 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Shah1">[2]</xref>
###xml 354 357 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Munro1">[4]</xref>
###xml 448 451 448 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Harper1">[5]</xref>
###xml 66 92 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
An estimated 2 million deaths occur annually due to infections of Mycobacterium tuberculosis, the causative agent of tuberculosis [1]. Multidrug-resistant tuberculosis, the recently discovered extensively drug-resistant form of the disease, and the numerous side effects of current drugs during the long course of drug treatment are ongoing problems [2]-[4]. Rifampicin, the newest first line antitubercular drug was introduced nearly 45 years ago [5]. Consequently there is an urgent need for identifying new drug targets and inhibitors that can effectively combat this disease.
###end p 9
###begin p 10
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Hardy1">[6]</xref>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 396 403 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g001">Fig. 1A</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Carreras1">[7]</xref>
###xml 568 571 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Ingraham1">[8]</xref>
###xml 573 576 573 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Curtin1">[9]</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Touroutoglou1">[10]</xref>
###xml 960 964 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Stout1">[11]</xref>
###xml 1072 1087 1072 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1160 1175 1160 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1196 1200 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Rengarajan1">[12]</xref>
###xml 1206 1221 1206 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1300 1307 1300 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1339 1343 1339 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Myllykallio1">[13]</xref>
###xml 1384 1399 1384 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1474 1489 1474 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1569 1573 1569 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Jiang1">[14]</xref>
###xml 1575 1579 1575 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Rathod1">[15]</xref>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 1072 1087 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1160 1175 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1206 1221 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1384 1399 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1474 1489 <span type="species:ncbi:1773">M. tuberculosis</span>
In other human diseases, the enzyme thymidylate synthase (ThyA) is an attractive target for drug development [6]. ThyA catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to thymidine-5'-monophosphate (TMP) while utilizing N5,N10-methylene-5,6,7,8-tetrahydrofolate (mTHF) as the methyl donor and reductant in the reaction, yielding dihydrofolate (DHF) as a by-product (Fig. 1A) [7]. Even partial inhibition of ThyA causes an accumulation of 2'-deoxyuridine-5'-triphosphate (dUTP) and a cascade of events leading to "thymine-less" cell death [8], [9]. Many established and experimental anticancer drugs, such as 5-fluorouracil, Nolatrexed (AG337), Pemetrexed, and Raltitrexed (ZD1694), act through this enzyme [10]. Prior understanding of this general target in pharmacology, along with the vast number of potent lead inhibitors already available, should facilitate drug development against other indications including antibacterials [11]. It has recently been postulated that p-aminosalicylic acid, a commonly used antitubercular drug, involves M. tuberculosis ThyA, suggesting that inhibition of ThyA activity may be detrimental to M. tuberculosis growth and survival [12]. The M. tuberculosis genome sequence also lacks thymidine kinase, underscoring the essentiality of de novo TMP synthesis in this pathogen [13]. On this basis, selective inhibition of M. tuberculosis growth by ThyA inhibitors might not even require inhibitors selective for M. tuberculosis ThyA, as shown for the experimental treatment of malaria by inhibition of ThyA [14], [15].
###end p 10
###begin title 11
Different reaction complexities of ThyA and ThyX.
###end title 11
###begin p 12
(A) ThyA converts dUMP to TMP using mTHF as a cofactor. mTHF is regenerated by dihydrofolate reductase (DHFR) and serine hydroxymethyltransferase (SHMT). (B) ThyX converts dUMP to TMP using mTHF, NADPH, and FAD as cofactors. mTHF is regenerated by SHMT.
###end p 12
###begin p 13
###xml 38 53 38 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sampathkumar1">[16]</xref>
###xml 205 224 205 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Helicobacter pylori</italic>
###xml 229 248 229 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thermotoga maritima</italic>
###xml 250 265 250 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 391 398 391 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g001">Fig. 1B</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Myllykallio1">[13]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sampathkumar1">[16]</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Kuhn1">[17]</xref>
###xml 583 598 583 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Myllykallio1">[13]</xref>
###xml 817 832 817 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 863 867 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Ulmer1">[18]</xref>
###xml 1056 1060 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Myllykallio1">[13]</xref>
###xml 1123 1127 1123 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thyX</italic>
###xml 1221 1239 1221 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium thyX</italic>
###xml 1296 1300 1296 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sassetti1">[19]</xref>
###xml 1302 1306 1302 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sassetti2">[20]</xref>
###xml 38 53 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 205 224 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 229 248 <span type="species:ncbi:2336">Thermotoga maritima</span>
###xml 250 265 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 583 598 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 817 832 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1146 1152 <span type="species:ncbi:9606">humans</span>
In addition to the conventional ThyA, M. tuberculosis also appears to carry a flavin-dependent thymidylate synthase (FDTS or ThyX) [16]. Based on sequence and structural similarities to related enzymes in Helicobacter pylori and Thermotoga maritima, M. tuberculosis ThyX is expected to catalyze the reductive methylation of dUMP to afford TMP using mTHF as the methyl donor in the reaction (Fig. 1B) [13], [16], [17]. In other species, ThyX utilizes NADPH and a bound FAD chromophore as the reductant for the reaction. Indeed, crystal structure and sequence analysis have found that M. tuberculosis ThyX binds NADP+ and FAD and has no direct similarity to ThyA [13]. In addition, site directed mutagenesis studies have identified several amino acid residues, including a conserved "ThyX motif" that are necessary for M. tuberculosis ThyX tritium-release activity [18]. Direct confirmation of full thymidylate synthase activity and its kinetic properties are still necessary because of the low sequence homology of the ThyX family of enzymes across species [13]. There is pharmacological interest in this enzyme because the thyX gene is absent in humans and transposon site hybridization (TraSH) experiments indicate that Mycobacterium thyX is an essential gene for optimal growth of the pathogen [19], [20].
###end p 13
###begin p 14
###xml 168 183 168 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 511 526 511 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 168 183 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 511 526 <span type="species:ncbi:1773">M. tuberculosis</span>
Despite the genomic, crystallographic, and mutagenesis studies, many of the fundamental enzymatic properties, such as the substrate and inhibitor binding abilities, of M. tuberculosis ThyA and ThyX remain unknown. Understanding the biochemistry of these enzymes is a necessary foundation needed for prioritizing drug development strategies and assigning biological function with confidence. In this study, we report on the expression, purification, kinetic properties, and inhibitor-binding preferences of both M. tuberculosis ThyA and ThyX. While the kinetic constants for substrate binding are not unusual, both enzymes had surprisingly low turnover rates. This evolutionary strategy raises important questions about possible alternate or additional roles of these enzymes in microbial functions. Regarding drug development, given that individual cell types may be specifically targeted using selective transport and selective drug activation properties of the cell, our initial results suggest that fluorinated pyrimidines may be used to inhibit both thymidylate synthase enzymes simultaneously. In contrast different folate analogues may be customized to selectively inhibit one enzyme over another.
###end p 14
###begin title 15
Results and Discussion
###end title 15
###begin title 16
Expression and purification
###end title 16
###begin p 17
###xml 17 32 17 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 190 197 190 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g002">Fig. 2A</xref>
###xml 310 317 310 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g002">Fig. 2B</xref>
###xml 487 499 487 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacteria</italic>
###xml 529 544 529 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 589 596 589 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 692 699 692 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g002">Fig. 2A</xref>
###xml 902 909 902 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g002">Fig. 2B</xref>
###xml 1168 1172 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sampathkumar1">[16]</xref>
###xml 17 32 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 77 84 <span type="species:ncbi:562">E. coli</span>
###xml 529 544 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 589 596 <span type="species:ncbi:562">E. coli</span>
Histidine-tagged M. tuberculosis ThyA was overexpressed from BL21(DE3) pLysS E. coli. Purification by nickel affinity, ion-exchange, and size exclusion chromatography afforded pure protein (Fig. 2A). A total of 18.5 mg of pure protein was obtained from 1 L of bacterial culture. Size exclusion chromatography (Fig. 2B) suggested that the protein had an apparent mass of 57 kDa, which is within 10% of the predicted mass of a dimer (61.4 kDa). This is the first purification of ThyA from Mycobacteria. Similarly, histidine-tagged M. tuberculosis ThyX was overexpressed from BL21(DE3) pLysS E. coli. Again, purification by nickel affinity and ion-exchange chromatography afforded pure protein (Fig. 2A). A total of 8 mg of pure protein was obtained from 1 L of bacterial culture (more recent protein preparations have routinely yielded 20 mg of ThyX per liter of culture). Size exclusion chromatography (Fig. 2B) suggested that this protein had an apparent mass of 104 kDa, which is within 10% of the predicted mass of a tetramer (114.8 kDa). This agrees with the previously reported crystal structure, which shows that the enzyme exists as a tetramer when crystallized [16].
###end p 17
###begin title 18
###xml 12 27 12 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 12 27 <span type="species:ncbi:1773">M. tuberculosis</span>
Analysis of M. tuberculosis ThyA and ThyX by SDS-PAGE and size exclusion chromatography.
###end title 18
###begin p 19
###xml 96 117 96 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">materials and methods</xref>
###xml 170 185 162 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 199 201 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 222 237 210 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 281 296 265 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 409 424 385 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 438 440 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 461 476 433 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 672 693 644 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">materials and methods</xref>
###xml 170 185 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 222 237 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 281 296 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 409 424 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 461 476 <span type="species:ncbi:1773">M. tuberculosis</span>
(A) Purification of ThyA and ThyX analyzed by SDS-PAGE (Lanes: 1, Molecular weight markers (see materials and methods); 2, 15 microg soluble lysate fraction; 3, 2 microg M. tuberculosis ThyA after Ni2+ column; 4, 2 microg M. tuberculosis ThyA after Q-sepharose column; 5, 2 microg M. tuberculosis ThyA after size exclusion; 6, Same as 1; 7, 15 microg soluble lysate fraction from ThyX expression; 8, 2 microg M. tuberculosis ThyX after Ni2+ column; 9, 2 microg M. tuberculosis ThyX after Q-sepharose column. (B) Analysis of ThyA and ThyX by size exclusion chromatography. Protein standards (*) eluted at 47.79, 53.74, 59.69, 67.64, 72.62, 80.56, 94.80, and 102.65 mL (see materials and methods). ThyA (o) eluted at 84.35 mL. ThyX (square) eluted at 76.83 mL.
###end p 19
###begin title 20
Lack of autologous RNA binding
###end title 20
###begin p 21
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Chu1">[21]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Zhang1">[22]</xref>
###xml 345 358 345 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Chu1">[21]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Chu2">[23]</xref>
###xml 501 516 501 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 568 574 568 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g003">Fig. 3</xref>
###xml 694 709 694 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 335 340 <span type="species:ncbi:9606">Human</span>
###xml 345 358 <span type="species:ncbi:5833">P. falciparum</span>
###xml 501 516 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 694 709 <span type="species:ncbi:1773">M. tuberculosis</span>
Autologous RNA binding by the classical thymidylate synthase, ThyA, can play an important role in pharmacology. Whether a protein binds its own RNA, and whether the resulting autologous translational inhibition can be reversed with enzyme inhibitors, can be important contributing variables to species-specific drug action [21], [22]. Human and P. falciparum ThyA have been shown to bind their cognate mRNA coding sequence and to inhibit their own translation [21]-[23]. The mRNA binding abilities of M. tuberculosis ThyA and ThyX were probed using a gel-shift assay (Fig. 3). Neither ThyA nor ThyX were found to bind their own mRNA. These initial results suggest that the expression levels of M. tuberculosis ThyA and ThyX are not regulated by classic autologous translational feedback loops and instead may be dominated by regulation of RNA transcription.
###end p 21
###begin title 22
###xml 15 30 15 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 15 30 <span type="species:ncbi:1773">M. tuberculosis</span>
RNA binding by M. tuberculosis ThyA and ThyX.
###end title 22
###begin p 23
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 84 86 84 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 96 111 96 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 139 154 139 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 185 198 185 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 301 316 301 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 344 359 340 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 390 403 382 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 505 509 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Zhang1">[22]</xref>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 96 111 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 139 154 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 185 198 <span type="species:ncbi:5833">P. falciparum</span>
###xml 301 316 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 344 359 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 390 403 <span type="species:ncbi:5833">P. falciparum</span>
M. tuberculosis thymidylate synthases do not bind to their cognate mRNA. 0.35 nM of 32P labeled M. tuberculosis ThyX mRNA (lanes 1 and 2), M. tuberculosis ThyA mRNA (lanes 3 and 4), or P. falciparum DHFR-TS mRNA (lanes 5 and 6) was incubated in the presence or absence (lanes 1, 3, and 5) of purified M. tuberculosis ThyX (3.5 microM, lane 2), M. tuberculosis ThyA (3.5 microM, lane 4), or P. falciparum DHFR-TS (500 nM, lane 6). Unbound RNA was digested with 3 units of RNase T1 prior to electrophoresis [22].
###end p 23
###begin title 24
Activity and substrate binding
###end title 24
###begin p 25
###xml 42 57 42 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 111 117 111 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g004">Fig. 4</xref>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ThyA</italic>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Stout1">[11]</xref>
###xml 390 405 390 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 533 536 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Carreras1">[7]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Chenna1">[24]</xref>
###xml 579 594 579 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 671 691 671 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis thyX</italic>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sampathkumar1">[16]</xref>
###xml 838 842 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Myllykallio1">[13]</xref>
###xml 42 57 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 390 405 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
###xml 579 594 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 671 686 <span type="species:ncbi:1773">M. tuberculosis</span>
The thymidylate-synthesizing abilities of M. tuberculosis ThyA and ThyX were confirmed by reversed phase HPLC (Fig. 4). The products of the enzymatic reactions were loaded onto a C18 column and decreases in dUMP and increases in TMP were confirmed using known standards. This simple experiment was necessary, particularly for ThyX. ThyA genes are very highly conserved across species [11]. M. tuberculosis ThyA and the well studied human ThyA (PDB # 1HZW) have a 53% sequence identity, including several essential catalytic residues [7], [24], thus creating high confidence that M. tuberculosis ThyA would indeed catalyze synthesis of thymidylate. In contrast, while the M. tuberculosis thyX gene product contains certain sequence motifs and structural elements identifying it as a TS [16], overall homology between ThyX sequences is low [13] and there was no direct proof of its ability to synthesize thymidylate.
###end p 25
###begin title 26
###xml 17 32 17 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 17 32 <span type="species:ncbi:1773">M. tuberculosis</span>
HPLC analysis of M. tuberculosis ThyA and ThyX products.
###end title 26
###begin p 27
###xml 4 19 4 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 169 170 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 268 283 268 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 341 342 341 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 402 403 402 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 4 19 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 268 283 <span type="species:ncbi:1773">M. tuberculosis</span>
(A) M. tuberculosis ThyA reaction products. Based on absorbance at 260 nm, the peak corresponding to dUMP (tr = 8.8 min) decreases while the peak corresponding to TMP (tr = 11.1 min) increases over a 120 minute time course (0, 30, 60, and 120 minute time points). (B) M. tuberculosis ThyX reaction products. The peak corresponding to dUMP (tr = 8.8 min) decreases while the peak corresponding to TMP (tr = 11.1 min) increases over a 120 minute time course (0, 30, 60, and 120 minute time points).
###end p 27
###begin p 28
###xml 285 292 285 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002237-t001">Table 1</xref>
###xml 691 697 691 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g005">Fig. 5</xref>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g006">6</xref>
###xml 763 764 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 764 765 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 832 847 820 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 854 861 842 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002237-t002">Table 2</xref>
###xml 1002 1006 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Dolnick1">[25]</xref>
###xml 1008 1012 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Davisson1">[26]</xref>
###xml 1051 1066 1031 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1157 1164 1119 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002237-t002">Table 2</xref>
###xml 1332 1336 1282 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Graziani1">[27]</xref>
###xml 1337 1341 1287 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Agrawal1">[31]</xref>
###xml 832 847 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 933 938 <span type="species:ncbi:9606">human</span>
###xml 1051 1066 <span type="species:ncbi:1773">M. tuberculosis</span>
Thymidylate synthase activities of the isolated proteins were also verified using a tritium-release assay which depends on deprotonation at the 5-position of the pyrimidine ring. ThyA and ThyX produced 210 nmol and 9 nmol of tritiated water per minute per mg of protein, respectively (Table 1). ThyX activity was also verified by NADPH oxidation assay (data not shown). To examine substrate binding, the purified enzymes were assayed with increasing concentrations of either dUMP or mTHF, with varying concentrations of the second substrate. Similarly, ThyX was assayed with NADPH, with varying dUMP or mTHF. The enzymes displayed standard Michaelis-Menten curves for all substrates tested (Fig. 5 and 6). Fitting of the data to the appropriate equation revealed Km values of 4+/-0.7 microM for dUMP and 70+/-30 microM for mTHF for M. tuberculosis ThyA (Table 2). These values are similar to the experimentally determined values for human ThyA (1.8 or 2.5 microM for dUMP and 12 or 31 microM for mTHF) [25], [26]. The kinetic constants calculated for M. tuberculosis ThyX were 3+/-0.7 microM for dUMP, 4.0+/-1 microM for mTHF, and 47+/-10 microM for NADPH (Table 2). These values were also similar to experimentally determined values for other ThyX enzymes, 6-65 microM for dUMP, 20-24 microM for mTHF, and 26 microM-4 mM for NADPH [27]-[31].
###end p 28
###begin title 29
###xml 25 40 25 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 25 40 <span type="species:ncbi:1773">M. tuberculosis</span>
Steady-state kinetics of M. tuberculosis ThyA.
###end title 29
###begin p 30
(A) Titrations of mTHF (29, 143, 571, 1143 microM) with varying concentrations of dUMP (*, 1.875 microM; black triangle down, 3.75 microM; blacksquare, square, filled, 7.5 microM; diamond, 15 microM). (B) Double reciprocal plot of data from plot A showing a sequential reaction mechanism. (C) Titrations of dUMP (1.875 microM, 3.75 microM, 7.5 microM, 15 microM) with varying concentrations of mTHF (*, 29 microM; black triangle down, 143 microM; blacksquare, square, filled, 571 microM; diamond, 1143 microM). (D) Double reciprocal plot of data from plot C showing a sequential reaction mechanism. Lines in A and C are plots of Michaelis-Menten equations with calculated constants. Lines in B and D are linear regressions. Error bars are propagation of standard deviations.
###end p 30
###begin title 31
###xml 25 40 25 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 25 40 <span type="species:ncbi:1773">M. tuberculosis</span>
Steady-state kinetics of M. tuberculosis ThyX.
###end title 31
###begin p 32
(A) Titrations of mTHF (1.25, 2.5, 5, 10, 20 microM) with varying concentrations of dUMP (*, 1.25 microM; black triangle down, 2.5 microM; blacksquare, square, filled, 5 microM; diamond, 10 microM; black triangle, 20 microM). (B) Double reciprocal plot of data from plot A showing a sequential reaction mechanism. (C) Titrations of dUMP (1.25, 2.5, 5, 10, 20 microM) with varying concentrations of mTHF (*, 1.25 microM; black triangle down, 2.5 microM; blacksquare, square, filled, 5 microM; diamond, 10 microM; black triangle, 20 microM). (D) Double reciprocal plot of data from plot C showing a sequential reaction mechanism. (E) Titrations of NADPH (12.5, 25, 50, 100, 200 microM) with varying concentrations of mTHF (*, 1.25 microM; black triangle down, 2.5 microM; blacksquare, square, filled, 5 microM; diamond, 10 microM; black triangle, 20 microM) in the presence of 2.86 microM dUMP. (F) Double reciprocal plot of data from plot E showing a sequential reaction mechanism. Lines in A, C, and E are plots of Michaelis-Menten equations with calculated constants. Lines in B, D, and F are linear regressions. Error bars are propagation of standard deviations.
###end p 32
###begin title 33
###xml 16 31 16 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 16 31 <span type="species:ncbi:1773">M. tuberculosis</span>
Purification of M. tuberculosis ThyA and ThyX.
###end title 33
###begin title 34
###xml 40 55 40 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 26 31 <span type="species:ncbi:9606">Human</span>
###xml 40 55 <span type="species:ncbi:1773">M. tuberculosis</span>
Comparison of kinetics of Human ThyA to M. tuberculosis ThyA and ThyX.
###end title 34
###begin p 35
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 15 19 15 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Dev1">[46]</xref>
From Dev et al.[46].
###end p 35
###begin p 36
###xml 23 27 23 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Dolnick1">[25]</xref>
From Dolnick and Cheng [25].
###end p 36
###begin p 37
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 20 24 20 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Davisson1">[26]</xref>
From Davisson et al.[26].
###end p 37
###begin p 38
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 22 26 22 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Pendergast1">[44]</xref>
From Pendergast et al.[44].
###end p 38
###begin title 39
Inhibitor binding
###end title 39
###begin p 40
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Touroutoglou1">[10]</xref>
###xml 88 103 88 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 198 213 198 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 658 664 658 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g007">Fig. 7</xref>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g008">8</xref>
###xml 769 770 769 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 770 771 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 88 103 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 198 213 <span type="species:ncbi:1773">M. tuberculosis</span>
Many folate and nucleotide analogs target TS enzymes [10]. One interesting challenge in M. tuberculosis pharmacology is to determine which compound class will inhibit which TS enzyme. Inhibition of M. tuberculosis ThyA and ThyX by the potent nucleotide-based inhibitor FdUMP, and the folate-based inhibitor 1843U89, were analyzed using the tritium-release assay. Based on similarity between substrates and inhibitors, FdUMP was analyzed with respect to dUMP, and 1843U89 was probed with respect to mTHF. Titrating the enzyme with increasing concentrations of substrate with various concentrations of the inhibitors revealed standard Michaelis-Menten curves (Fig. 7 and 8). Fitting of the data to the appropriate equation, based on double reciprocal plots, provided the Ki values.
###end p 40
###begin title 41
###xml 14 29 14 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 14 29 <span type="species:ncbi:1773">M. tuberculosis</span>
Inhibition of M. tuberculosis ThyA by 1843U89 and FdUMP.
###end title 41
###begin p 42
(A) Titrations of mTHF (50, 150, 300, 600, 1200 microM) with varying concentrations of 1843U89 (*, 0 nM; black triangle down, 12.5 nM; blacksquare, square, filled, 25 nM; diamond, 50 nM; black triangle, 75 nM) in the presence of 3.75 microM dUMP. (B) Double reciprocal plot of data from plot A showing a noncompetitive inhibition mechanism. (C) Titrations of dUMP (1.25, 2.5, 5, 10 microM) with varying concentrations of FdUMP (*, 0 nM; black triangle down, 2.5 nM; blacksquare, square, filled, 5 nM; diamond, 10 nM) in the presence of 142.9 microM mTHF. (D) Double reciprocal plot of data from plot C showing a noncompetitive inhibition mechanism. Lines in A and C are plots of Michaelis-Menten equations with calculated constants. Lines in B and D are linear regressions. Error bars are propagation of standard deviations.
###end p 42
###begin title 43
###xml 14 29 14 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 14 29 <span type="species:ncbi:1773">M. tuberculosis</span>
Inhibition of M. tuberculosis ThyX by 1843U89 and FdUMP.
###end title 43
###begin p 44
(A) Titrations of mTHF (1.25, 2.5, 10, 20 microM) with varying concentrations of 1843U89 (*, 0 microM; black triangle down, 25 microM; blacksquare, square, filled, 50 microM; diamond, 100 microM; black triangle, 400 microM) in the presence of 2.86 microM dUMP. (B) Double reciprocal plot of data from plot A showing a noncompetitive inhibition mechanism. (C) Titrations of dUMP (1.25, 2.5, 5, 7.5, 10 microM) with varying concentrations of FdUMP (*, 0 nM; black triangle down, 250 nM; blacksquare, square, filled, 500 nM; diamond, 750 nM; black triangle, 1000 nM) in the presence of 8 microM mTHF. (D) Double reciprocal plot of data from plot C showing a mixed inhibition mechanism. Lines in A and C are plots of Michaelis-Menten equations with calculated constants. Lines in B and D are linear regressions. Error bars are propagation of standard deviations.
###end p 44
###begin p 45
###xml 36 43 36 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002237-t002">Table 2</xref>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 187 188 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Rathod1">[15]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Gomez1">[32]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Rathod2">[33]</xref>
FdUMP inhibited both ThyA and ThyX (Table 2). While this nucleotide-based inhibitor is a more potent inhibitor of ThyA (Ki, 2 nM), it still shows mid-nanomolar level inhibition of ThyX (Ki, 100 nM). This implies that fluorinated pyrimidine analogs could be used to inhibit both enzymes simultaneously. Again, specificity may be achieved from selection of appropriate fluorinated nucleotide, as is the case in experimental malaria chemotherapy [15], [32], [33].
###end p 45
###begin p 46
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002237-t002">Table 2</xref>
###xml 216 231 216 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 261 276 261 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 409 424 409 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 492 505 492 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 690 710 690 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum enzyme</italic>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Baldwin1">[34]</xref>
###xml 806 819 806 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Baldwin2">[35]</xref>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Phillips1">[36]</xref>
###xml 1043 1058 1043 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 216 231 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 261 276 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 409 424 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 492 505 <span type="species:ncbi:5833">P. falciparum</span>
###xml 548 553 <span type="species:ncbi:9606">human</span>
###xml 668 673 <span type="species:ncbi:9606">human</span>
###xml 690 703 <span type="species:ncbi:5833">P. falciparum</span>
###xml 806 819 <span type="species:ncbi:5833">P. falciparum</span>
###xml 831 836 <span type="species:ncbi:9606">human</span>
###xml 1043 1058 <span type="species:ncbi:1773">M. tuberculosis</span>
While 1843U89 inhibited ThyA with a Ki of 18 nM, it displaying a 600-fold weaker binding to ThyX (Table 2). This compound was originally designed to inhibit human ThyA which is very similar in amino acid sequence to M. tuberculosis ThyA and quite dissimilar to M. tuberculosis ThyX. Just as 1843U89 is highly selective for ThyA over ThyX, basic thermodynamic principles suggest that reciprocal inhibitors for M. tuberculosis ThyX should exist. Such is the case in the selective inhibition of P. falciparum dihydroorotate dehydrogenase (DHODH) over human DHODH. Initially, it was shown that common DHODH inhibitors were approximately 2,000-5,000-fold selective for the human enzyme over the P. falciparum enzyme[34]. A subsequent high-throughput screen identified inhibitors up to 12,500-fold selective for P. falciparum DHODH over human DHODH [35], [36]. In addition to implications for future drug development strategies, TS-selective folate inhibitors should play an important role in untangling the biological roles of these two enzymes in M. tuberculosis biology.
###end p 46
###begin title 47
Low turnover
###end title 47
###begin p 48
###xml 46 61 46 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 144 147 144 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 215 218 215 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 234 236 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 427 428 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 428 431 428 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Ackermann1">[37]</xref>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Cha2">[39]</xref>
###xml 625 631 625 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g009">Fig. 9</xref>
###xml 46 61 <span type="species:ncbi:1773">M. tuberculosis</span>
The present kinetic experiments revealed that M. tuberculosis ThyA and ThyX have very low catalytic rates for the synthesis of TMP. Initially, Vmax with known protein amounts in the reactions, we obtained apparent kcat values of 6 min-1 and 0.25 min-1 for ThyA and ThyX respectively. To rule out potential artifacts due to misfolded or inactive protein, the method of Ackermann and Potter was applied to determine the absolute kcat values of catalytically active ThyA and ThyX protein molecules [37]-[39]. Activity was determined with varying amounts of the purified enzymes titrated with increasing concentrations of FdUMP (Fig. 9).
###end p 48
###begin title 49
Ackermann-Potter plots of ThyA and ThyX activity.
###end title 49
###begin p 50
###xml 135 150 135 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 674 689 603 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 135 150 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 674 689 <span type="species:ncbi:1773">M. tuberculosis</span>
(A) Graph of x-intercepts from primary plot lines (inset) versus FdUMP concentration (0, 10, 20, 30, 40 nM). Inset plot: titrations of M. tuberculosis ThyA with varying concentrations of FdUMP in the presence of 1200 microM mTHF and 20 microM dUMP. *, 0 nM FdUMP (20, 35, 50, 65, 80 ng ThyA); black triangle down, 10 nM FdUMP (50, 65, 80, 95, 110 ng ThyA); blacksquare, square, filled, 20 nM FdUMP (80, 95, 110, 125 ng ThyA); diamond, 30 nM FdUMP (110, 125, 140, 155 ng ThyA); black triangle, 40 nM FdUMP (155, 170, 185, 200 ng ThyA). (B) Graph of x-intercepts from primary plot lines (inset) versus FdUMP concentration (0, 125, 250, 375, 500 nM). Inset plot: titrations of M. tuberculosis ThyX with varying concentrations of FdUMP in the presence of 20 microM mTHF, 20 microM dUMP, 1 mM NADPH, and 10 microM FAD. *, 0 nM FdUMP (1.25, 1.5, 1.75, 2, 2.25 microg ThyX); black triangle down, 125 nM FdUMP (1.25, 1.5, 1.75, 2 microg ThyX); blacksquare, square, filled, 250 nM FdUMP (1.5, 1.75, 2, 2.25, 2.5 microg ThyX); diamond, 375 nM FdUMP (2, 2.25, 2.5, 2.75 microg ThyX); black triangle, 500 nM FdUMP (2, 2.25, 2.5, 2.75 microg ThyX). Error bars were omitted to simplify the graphs.
###end p 50
###begin p 51
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 77 80 77 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 103 118 103 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 197 210 197 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. falciparum</italic>
###xml 224 226 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 238 240 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Davisson1">[26]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-HekmatNejad1">[40]</xref>
###xml 292 307 292 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 338 341 338 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Graziani1">[27]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Leduc1">[28]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Griffin1">[30]</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Agrawal1">[31]</xref>
###xml 580 595 580 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Agrawal1">[31]</xref>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Gattis1">[41]</xref>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sampathkumar2">[42]</xref>
###xml 991 999 991 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1064 1071 1064 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1181 1196 1181 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1872 1876 1872 1876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-VanTriest1">[43]</xref>
###xml 103 118 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 197 210 <span type="species:ncbi:5833">P. falciparum</span>
###xml 292 307 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 580 595 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1181 1196 <span type="species:ncbi:1773">M. tuberculosis</span>
The slopes from the primary and secondary Ackermann-Potter plots revealed a kcat value of 18 min-1 for M. tuberculosis ThyA. This is still an order of magnitude lower than the values for human and P. falciparum ThyA (150 min-1 and 120 min-1, respectively [26], [40]). The rate of turnover by M. tuberculosis ThyX was even slower, with a kcat value of 0.4 min-1. This too was determined using the Ackermann-Potter method. Of all the ThyX enzymes studied from other microorganisms, which show as much as 100-fold variations in specific activity for ThyX [27], [28], [30], [31], the M. tuberculosis ThyX enzyme is the slowest. The ThyA and ThyX turnover numbers raise some important biological questions relevant to TB pharmacology. Due to the low turnover rates of ThyX enzymes in general, several studies have questioned whether the true biological substrates for this enzyme have been identified [31], [41], [42]. While the substrates used in the present work were able to catalyze turnover in vitro, it is possible that they do not provide an accurate measure of in vivo activity. Alternatively, the low turnover rate may be related to an important evolutionary characteristic of M. tuberculosis. It is a very slow growing pathogen, presumably with limited needs for TMP. Normally, one would assume that such an organism would evolve to down-regulate thymidylate synthesizing protein expression, compared to rapidly proliferating cells. The present chemical data raises the possibility that this slow-growing pathogen may have evolved to decrease the catalytic activity of individual enzyme molecules, perhaps to preserve total protein quantities for other purposes. Cellular role of TS proteins can extend beyond generating TMP. ThyA is often found as a part of a larger complex of proteins and RNA that are involved in control of cell replication as well as DNA repair [43]. If ThyA levels and ThyX levels are not low, development of pathogen inhibitors will have to rely on selectivity mechanism other than low target levels.
###end p 51
###begin title 52
Concluding remarks
###end title 52
###begin p 53
###xml 84 99 84 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 176 191 176 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 443 458 443 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 781 796 781 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 885 900 885 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 84 99 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 176 191 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 322 327 <span type="species:ncbi:9606">human</span>
###xml 443 458 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 781 796 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 885 900 <span type="species:ncbi:1773">M. tuberculosis</span>
The present chemical studies help to set the initial foundation to further evaluate M. tuberculosis ThyA and ThyX as chemotherapeutic targets against tuberculosis. Even though M. tuberculosis carries two genes for thymidylate synthesis, both of which have been implicated as important in growth and survival of this major human pathogen, the biological data available to date do not define the detailed metabolic role and the vulnerability of M. tuberculosis to inhibitors of these enzymes. If detailed genetic manipulations of individual genes formally show that both genes are essential, chemical genetic approaches based on the present enzymatic studies will follow. These should facilitate an understanding of whether target inhibition of one or both enzymes is needed to kill M. tuberculosis in its growth phase, whether target inhibition of one or both enzymes is needed to kill M. tuberculosis in its latent phase, whether the bacteria can upregulate each of the proteins in the presence of inhibitors to overcome drug action, whether one gene can facilitate resistance to inhibitors directed at the other TS, and whether selective dual targeting may be required to successfully shut off TMP synthesis.
###end p 53
###begin title 54
Materials and Methods
###end title 54
###begin title 55
Reagents
###end title 55
###begin p 56
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 748 756 748 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 916 918 912 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1147 1148 1143 1144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1393 1397 1383 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Pendergast1">[44]</xref>
FAD, NADPH, tetrahydrofolic acid, Pefabloc SC, DNAseI, FdUMP, dUMP, TMP and protein standards for size-exclusion chromatography were purchased from Sigma-Aldrich (St. Louis, MO). [5-3H]-dUMP was purchased from Moravek Biochemicals (Brea, CA). His GraviTrap columns, DEAE Sepharose Fast Flow, Q Sepharose Fast Flow, and Superdex 200 were purchased from GE Healthcare (Piscataway, NJ). Protein concentrations were measured using the Protein Assay kit from Bio-Rad Laboratories (Hercules, CA). Low-range protein molecular weight markers were obtained from Bio-Rad Laboratories (Hercules, CA) (phosphorylase b, 97,400; serum albumin, 66,200; ovalbumin, 45,000; carbonic anhydrase, 31,000; trypsin inhibitor, 21,500; lysozyme, 14,400). The T7 Riboprope in vitro transcription system was obtained from Promega (Madison, WI). RNasin and RNase T1 were purchased from Ambion (Foster City, CA). Uridine 5'-triphosphate [alpha-32P] was purchased from American Radiolabeled Chemicals (St. Louis, MO). To prepare a 20 mM stock solution of methylene tetrahydrofolate (mTHF), solid tetrahydrofolic acid was dissolved in a buffer containing 125 mM TES, 60 mM MgCl2, 2.5 mM EDTA (pH 8.0), 190 mM 2-mercaptoethanol, and 16 mM formaldehyde. All, more dilute, mTHF solutions were made from this stock solution. mTHF solutions were stored under argon at -20degreesC. 1843U89 was synthesized as previously reported [44].
###end p 56
###begin title 57
###xml 31 46 31 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 31 46 <span type="species:ncbi:1773">M. tuberculosis</span>
Expression and purification of M. tuberculosis ThyA
###end title 57
###begin p 58
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">thyA</italic>
###xml 160 167 160 167 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCT AGC</underline>
###xml 152 231 152 231 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTA CCA <underline>GCT AGC</underline> CTC GAG ATG CAC CAC CAC CAC CAC CAC ACG CCA TAC GAG GAC CTG CTG</named-content>
###xml 265 272 265 272 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAG CTC</underline>
###xml 257 314 257 314 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTT ATT <underline>GAG CTC</underline> CCC GGG TCA TAC CGC GAC TGG AGC TTT GAT C</named-content>
###xml 471 478 471 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 719 725 705 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 471 478 <span type="species:ncbi:562">E. coli</span>
The thyA gene was cloned from a pET24d(+) vector with a C-terminal His-Tag into a pET23d(+) vector with an N-terminal His-Tag using the forward primer (TTA CCA GCT AGC CTC GAG ATG CAC CAC CAC CAC CAC CAC ACG CCA TAC GAG GAC CTG CTG) and the reverse primer (GTT ATT GAG CTC CCC GGG TCA TAC CGC GAC TGG AGC TTT GAT C) including NheI and SacI restriction sites (underlined) and the plasmid construct was confirmed by sequencing. The protein was expressed in BL21(DE3) pLysS E. coli in 100 mL LB media containing 50 microg/mL ampicillin and 35 microg/mL chloramphenicol at 37degreesC overnight. About 50 mL of the overnight culture was added to 1 L of LB with the appropriate antibiotics. The 1 L culture was grown to an OD600 nm of 0.6 and IPTG was added to give a final IPTG concentration of 1 mM. After 6 hours, the cells were harvested by centrifugation at 10,000xg at 4degreesC and the cells were resuspended, on ice, in 20 mM sodium phosphate (pH 7.4), 500 mM sodium chloride, 15 mM magnesium chloride, 20 mM imidazole, 20 microg/mL DNAseI, 1 mM Pefabloc SC, and 0.2 mg/mL lysozyme and lysed by sonication. Cell debris was removed by centrifugation at 10,000xg at 4degreesC and the cleared lysate was purified on a His GraviTrap column as specified by the manufacturer. The crudely purified protein was dialyzed against 75 mM potassium phosphate (pH 7.8), 0.1 mM EDTA, and 1 mM DTT and bound to a DEAE Sepharose Fast Flow column. The protein was eluted with a 0-250 mM NaCl gradient. Fractions containing ThyA were pooled, concentrated, and purified on a Superdex 200 size exclusion column with elution by 20 mM Tris (pH 7.8), 150 mM KCl, 1 mM DTT, and 0.1 mM EDTA. The enzyme was frozen at -20degreesC in the same buffer containing 20% glycerol.
###end p 58
###begin title 59
###xml 31 46 31 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 31 46 <span type="species:ncbi:1773">M. tuberculosis</span>
Expression and purification of M. tuberculosis ThyX
###end title 59
###begin p 60
###xml 13 33 13 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis thyX</italic>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Sampathkumar1">[16]</xref>
###xml 106 108 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 13 28 <span type="species:ncbi:1773">M. tuberculosis</span>
The gene for M. tuberculosis thyX with a C-terminal His-Tag was expressed as above [16]. ThyX bound the Ni2+ column tightly and was eluted with 20 mM sodium phosphate (pH 7.4), 1M NaCl, and 1M imidazole. The crudely purified protein was dialyzed, against 10 mM Tris HCl (pH 7.2), 50 mM NaCl, and 2 mM DTT, and bound to a Q Sepharose Fast Flow column. The protein was eluted with a 50-500 mM NaCl gradient. Fractions containing ThyX were pooled, dialyzed against 50 mM Tris HCl (pH 7.5), 200 mM NaCl, and 10% glycerol, and frozen at -20degreesC.
###end p 60
###begin title 61
Protein size
###end title 61
###begin p 62
###xml 1027 1031 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Whitaker1">[45]</xref>
###xml 290 296 <span type="species:ncbi:9913">bovine</span>
The approximate masses of ThyA and ThyX, in solution, were determined using size-exclusion chromatography. A mixture of protein standards consisting of: Blue Dextran (void volume marker), thyroglobulin (669 kDa), apoferritin (443 kDa), b-amylase (200 kDa), alcohol dehydrogenase (150 kDa), bovine serum albumin (66 kDa), carbonic anhydrase (29 kDa), and cytochrome C (12.4 kDa), was loaded onto a Superdex 200 size-exclusion column with a bed volume of 120 mL (the concentration of the standards was 1-2 mg/mL for each protein). The standards were eluted with 20 mM potassium phosphate (pH 7.8), 150 mM KCl, 1 mM DTT, and 0.1 mM EDTA with a flow rate of 0.7 mL/min. Samples of ThyA and ThyX were loaded onto the column at a concentration of approximately 1.5 mg/mL and eluted with the same buffer and flow rate. A plot of elution volume/void volume versus log of the molecular weight standards gave a linear data set whose regression line was used to calculate thymidylate synthase molecular weight from enzyme elution volumes [45].
###end p 62
###begin title 63
RNA binding assay
###end title 63
###begin p 64
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Chu1">[21]</xref>
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Zhang1">[22]</xref>
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 359 365 359 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260 nm</sub>
###xml 565 567 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 609 611 597 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 708 710 696 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 806 807 794 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
RNA binding experiments was measured as previously described [21], [22]. ThyA and ThyX mRNA was generated using the T7 Riboprobe in vitro transcription system (Promega) following the manufacturers protocol. The RNA was purified by phenol/chloroform extraction followed by ethanol precipitation. The amount of RNA transcribed was determined by measuring the OD260 nm of the solution. Electrophoresis using 1% formamide agarose was used to determine the size and integrity of the RNA. Radiolabeled RNA was made by using 12 microM rUTP and adding 50 microCi of [alpha-32P] UTP. Labeled RNA was quantified by the 32P-incorporation assay following the protocol from Promega. RNA (0.35 nM labeled with 100,000 cpm 32P) was incubated with varying concentrations of purified enzyme in 10 mM HEPES pH 7.5, 3 mM MgCl2, 40 mM KCl, 5% glycerol, 200 mM 2-mercaptoethanol, and 1 unit of RNasin at 37degreesC for 15 minutes. The unbound RNA was digested by addition of 3 units of RNase T1 and incubation at 25degreesC for 10 minutes. Non-specific interactions were reduced by addition of 5 mg/ml heparin and incubation at 25degreesC for 10 minutes. The RNA-protein complexes were resolved on a 5% TBE polyacrylamide gel and visualized by autoradiography.
###end p 64
###begin title 65
TMP synthesis
###end title 65
###begin p 66
###xml 24 39 24 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 61 76 57 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 24 39 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 61 76 <span type="species:ncbi:1773">M. tuberculosis</span>
Approximately 150 ng of M. tuberculosis ThyA, or 3 microg of M. tuberculosis ThyX, was added to a mixture of 60 microL mTHF (final mTHF concentrations were 143 microM for ThyA assay or 20 microM for ThyX assay), 15 microL of 140 microM dUMP, 3 microL of 350 microM FAD (for ThyX assay only), and 1 microL of 35 mM NADPH (for ThyX assay only) and water to give reaction volume of 105 microL. The reaction times varied from 30 to 120 minutes. To isolate the products, the reaction mixture was spun through a Microcon YM-10 centrifugal filter (MWCO = 10,000) at 13,000xg for 5 minutes. An additional 100 microL of water was added and the spin was repeated. The deproteinized reaction mixture was run on an HPLC using a Beckman reversed phase Ultrasphere ODS 5 microm C-18 column (4.6 mm ID, 150 mm length) with isocratic flow with 5 mM potassium phosphate (pH 7.0), 5 mM tetrabutylammonium dihydrogen phosphate, and 5% (v/v) acetonitrile, while monitoring elution at 260 nm. Standard solutions of dUMP, TMP, and mTHF were also run to assign the elution positions of reactants and products.
###end p 66
###begin title 67
Thymidylate synthase assay
###end title 67
###begin p 68
###xml 46 61 46 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 82 97 78 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 518 519 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1133 1136 1059 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 46 61 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 82 97 <span type="species:ncbi:1773">M. tuberculosis</span>
In a standard tritium-release assay, 50 ng of M. tuberculosis ThyA or 1 microg of M. tuberculosis ThyX, in 1 microL, was added to 20 microL mTHF (mTHF concentrations in the reactions ranged from 5.7 microM-1143 microM for ThyA assay or 1.25 microM-20 microM for ThyX assay), 1 microL of 200 microM FAD (for ThyX assay only), and 1 microL of 2 mM NADPH (for ThyX assay only). The total reaction volume was brought to 30 microL with the addition of water. To initiate the reaction, 5 microL of 13.1 microM-140 microM [5-3H]-dUMP (0.4 Ci/mmol) was added. After a 25 minute reaction period, at room temperature, the reaction was terminated by the addition of 20 microL of a stop solution (a 3:1 ratio of 2 N TCA:4.3 mM dUMP). To remove unreacted substrates, 200 microL 10% (w/v) activated charcoal in water was added to the reaction mixture. The reaction tubes were incubated on ice for 15 minutes then spun at 13,000xg at 4degreesC for 10 minutes. A 100 microL aliquot of the supernatant was assayed by liquid scintillation counting to determine the amount of tritium-containing water produced by the reaction. Specific activities and Vmax values were determined in the presence of saturating concentrations of substrates.
###end p 68
###begin title 69
Kinetic properties
###end title 69
###begin p 70
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 148 151 148 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 213 219 213 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g005">Fig. 5</xref>
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g006">6</xref>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g009">9</xref>
###xml 433 436 433 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 453 454 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 454 455 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sup>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</sup>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 467 468 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 468 469 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</sup>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 470 471 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 471 472 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sup>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 476 479 476 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 561 564 561 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 575 576 575 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Ackermann1">[37]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002237-Cha2">[39]</xref>
###xml 608 614 608 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g009">Fig. 9</xref>
The tritium release, at fixed time points, revealed initial reaction velocities needed to calculate the Km values of dUMP, mTHF, and NADPH and the kcat values of thymidylate synthase activity. See the legends for Fig. 5, 6, and 9 for substrate concentrations. Plots of reaction velocity (v) versus substrate concentration (A and/or B) were fit, using SigmaPlot 9.0, to the Michaelis-Menten equation for a sequential mechanism: v = (Vmax[A][B])/([A][B]+KmA[B]+KmB[A]+KmBKsA). kcat values were determined from Ackermann-Potter plots using the equation, Slope = (kcat[S])/([S]+Km) [37]-[39]. See the legend for Fig. 9 for enzyme and inhibitor concentrations.
###end p 70
###begin title 71
Inhibitory constants
###end title 71
###begin p 72
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 209 215 209 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g007">Fig. 7</xref>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002237-g008">8</xref>
###xml 606 609 606 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 623 624 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 626 627 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 627 628 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 628 629 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</sup>
###xml 656 659 656 659 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 666 667 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 667 668 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</sup>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 676 677 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 710 713 710 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 719 720 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 720 721 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</sup>
###xml 729 730 729 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 730 731 730 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 743 744 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 744 746 744 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">is</sub>
The tritium-release assay was also used to determine the Ki values of the inhibitors for the ThyA and ThyX enzymes. Inhibitor and corresponding substrate concentrations were varied as listed in the legends of Fig. 7 and 8 (dUMP was varied against changing FdUMP in the reactions and mTHF was varied against changing 1843U89 in the reactions). The data yielded double reciprocal plots that were fit to linear regression lines. Plots of reaction velocity versus substrate concentration were fit, using SigmaPlot 9.0, to the appropriate Michaelis-Menten equation for an inhibition by a non-competitive: v = (Vmax[B])/((1+[I]/Ki)(KmB+[B])), competitive: v = (Vmax[B])/(KmB(1+[I]/Ki+[B]), or mixed inhibitor: v = (Vmax[B])/(KsA(1+[I]/Ki)+[B](1+[I]/Kis)).
###end p 72
###begin p 73
###xml 159 185 159 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 159 185 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The authors thank Carol Hopkins Sibley and Jonathan E. Ulmer (Department of Genome Sciences, University of Washington) for DNA templates used to construct the Mycobacterium tuberculosis ThyA and ThyX expression vectors for this paper.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
Reducing the global burden of tuberculosis: the contribution of improved diagnostics.
###end article-title 75
###begin article-title 76
Worldwide emergence of extensively drug-resistant tuberculosis.
###end article-title 76
###begin article-title 77
Tuberculosis chemotherapy: current drug delivery approaches.
###end article-title 77
###begin article-title 78
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient adherence to tuberculosis treatment: a systematic review of qualitative research.
###end article-title 78
###begin article-title 79
Tuberculosis, a neglected opportunity?
###end article-title 79
###begin article-title 80
Atomic structure of thymidylate synthase: target for rational drug design.
###end article-title 80
###begin article-title 81
The catalytic mechanism and structure of thymidylate synthase.
###end article-title 81
###begin article-title 82
DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate.
###end article-title 82
###begin article-title 83
Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole.
###end article-title 83
###begin article-title 84
Thymidylate synthase inhibitors.
###end article-title 84
###begin article-title 85
Structure-based design of inhibitors specific for bacterial thymidylate synthase.
###end article-title 85
###begin article-title 86
The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
###end article-title 86
###begin article-title 87
An alternative flavin-dependent mechanism for thymidylate synthesis.
###end article-title 87
###begin article-title 88
###xml 128 149 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum.
###end article-title 88
###begin article-title 89
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 68 89 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum.
###end article-title 89
###begin article-title 90
###xml 17 43 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Structure of the Mycobacterium tuberculosis flavin dependent thymidylate synthase (MtbThyX) at 2.0A resolution.
###end article-title 90
###begin article-title 91
###xml 77 96 <span type="species:ncbi:2336">Thermotoga maritima</span>
Crystal structure of thy1, a thymidylate synthase complementing protein from Thermotoga maritima at 2.25 A resolution.
###end article-title 91
###begin article-title 92
###xml 27 53 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Functional analysis of the Mycobacterium tuberculosis FAD-dependent thymidylate synthase, ThyX, reveals new amino acid residues contributing to an extended ThyX motif.
###end article-title 92
###begin article-title 93
Genes required for mycobacterial growth defined by high density mutagenesis.
###end article-title 93
###begin article-title 94
Genetic requirements for mycobacterial survival during infection.
###end article-title 94
###begin article-title 95
###xml 18 23 <span type="species:ncbi:9606">human</span>
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.
###end article-title 95
###begin article-title 96
###xml 77 82 <span type="species:ncbi:9606">human</span>
Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
###end article-title 96
###begin article-title 97
###xml 42 47 <span type="species:ncbi:9606">human</span>
Identification of an RNA binding site for human thymidylate synthase.
###end article-title 97
###begin article-title 98
Multiple sequence alignment with the Clustal series of programs.
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Human thymidylate synthetase derived from blast cells of patients with acture myelocytic leukemia. Purification and chracterization.
###end article-title 99
###begin article-title 100
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 44 60 <span type="species:ncbi:562">Escherichia coli</span>
Expression of human thymidylate synthase in Escherichia coli.
###end article-title 100
###begin article-title 101
###xml 68 87 <span type="species:ncbi:74790">Paramecium bursaria</span>
###xml 88 103 <span type="species:ncbi:10507">Chlorella virus</span>
Functional analysis of FAD-dependent thymidylate synthase ThyX from Paramecium bursaria Chlorella virus-1.
###end article-title 101
###begin article-title 102
Functional evidence for active site location of tetrameric thymidylate synthase X at the interphase of three monomers.
###end article-title 102
###begin article-title 103
Catalytic mechanism and structure of viral flavin-dependent thymidylate synthase ThyX.
###end article-title 103
###begin article-title 104
###xml 23 44 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Catalytic mechanism of Chlamydia trachomatis flavin-dependent thymidylate synthase.
###end article-title 104
###begin article-title 105
Mechanistic studies of a flavin-dependent thymidylate synthase.
###end article-title 105
###begin article-title 106
###xml 73 77 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice.
###end article-title 106
###begin article-title 107
###xml 50 71 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro.
###end article-title 107
###begin article-title 108
Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity.
###end article-title 108
###begin article-title 109
###xml 65 86 <span type="species:ncbi:5833">Plasmodium falciparum</span>
High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
###end article-title 109
###begin article-title 110
###xml 130 151 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite, Plasmodium falciparum.
###end article-title 110
###begin article-title 111
Enzyme inhibition in relation to chemotherapy.
###end article-title 111
###begin article-title 112
###xml 131 136 <span type="species:ncbi:9606">human</span>
Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin.
###end article-title 112
###begin article-title 113
Tight-binding inhibitors-I. Kinetic behavior.
###end article-title 113
###begin article-title 114
###xml 12 33 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Kinetics of Plasmodium falciparum thymidylate synthase: interactions with high-affinity metabolites of 5-fluoroorotate and D1694.
###end article-title 114
###begin article-title 115
Direct observation of the participation of flavin in product formation by thyX-encoded thymidylate synthase.
###end article-title 115
###begin article-title 116
###xml 64 90 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
NADP+ expels both the co-factor and a substrate analog from the Mycobacterium tuberculosis ThyX active site: opportunities for anti-bacterial drug design.
###end article-title 116
###begin article-title 117
Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors.
###end article-title 117
###begin article-title 118
Benzo[f]quinazoline inhibitors of thymidylate synthase: methyleneamino-linked aroylglutamate derivatives.
###end article-title 118
###begin article-title 119
Determination of Molecular Weights of Proteins by Gel Filtration of Sephadex.
###end article-title 119
###begin article-title 120
Mode of binding of folate analogs to thymidylate synthase. Evidence for two asymmetric but interactive substrate binding sites.
###end article-title 120
###begin p 121
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 121
###begin p 122
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH grants AI26912 and AI60360 and a Senior Scholar Award in Global Infectious Diseases from the Ellison Medical Foundation (PKR).
###end p 122

